ABIONYX Pharma Announces That the French Drug Safety Agency (Agence Nationale de Sécurité du Médicament or ANSM) Has Granted a Compassionate Access Authorization for the bio-HDL (CER-001) in COVID-19 Disease

Regulatory News: ABIONYX Pharma (FR0012616852 ABNX PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies for patients, today announces

Related Keywords

France ,Arthur Rouill ,Louis Victor Delouvrier ,French Drug Safety Agency Agence Nationale De ,Regulatory News ,French Drug Safety Agency ,Agence Nationale ,Compassionate Access Authorization ,Temporary Authorizations ,Compassionate Access Authorizations ,Victor Delouvrier ,Abionyx ,Dharma ,Nnounces ,Hat ,French ,Drug ,Safety ,Agency ,Surgence ,Nationale ,S 233 Curit ,M 233 Dicament ,Insm ,Granted ,Compassionate ,Access ,Authorization ,Covid ,Disease ,